Our Promise

Product Innovation Advancing
Patient Care with Excellence

Our Mission

To leverage internal expertise and external relationships to rapidly deliver high quality, low cost, high margin medical devices to the orthopedic market with a value proposition that is the right balance for the surgeon, hospital administration, OR staff, distributor, and patient.

Core Principles

  • World-class scalable manufacturing
  • Lean operational discipline and superior quality
  • Accelerated R&D pipeline
  • Novel intellectual property
  • Inspire to be the industry leader

About Curiteva


Curiteva is a privately held technology and manufacturing company based in Huntsville, AL. The company was founded in 2017 in a 35,000 sq ft facility by a machinist entrepreneur, focusing on building a portfolio of proprietary spinal implants. Since its founding, Curiteva is pioneering 3D printing of porous PEEK implants with a bioactive nano-surface to revolutionize how engineered structures and implant biomaterials accelerate immunomodulation, enhance healing, and improve patient outcomes.

Leadership

Curiteva’s leadership team and their unwavering commitment to product and process excellence is foundational to success.

Founder and Chairman of the Board

Chad Falciani

Founder and Chief Technology Officer

Eric Linder

Chief Scientific Officer

Erik Erbe, PhD

Chief Commercial Officer

David Schmidt

Chief Financial Officer

Phil Cupero

Chief Operating Officer

Bill Voss

Executive Vice President

Mark Mohlman

Vice President of Emerging Technology

Todd Reith

In the News

Unique Osseointegration Patterns in 3D Printed Trabecular-Architecture Porous Polyetheretherketone (PEEK). A CT Scan Study of the Inspire® Cervical Implant

Anterior cervical discectomy and fusion (ACDF) is a common procedure for the surgical treatment of degenerative pathologies of the cervical spine. The utilization of interbody fusion implants is a well-established technique to restore disk space height, alignment, decompress the exiting nerve roots, and provide surface area for fusion of the adjacent vertebrae. Successful fusion is critical for the long-term stability and function of the cervical spine and for maintenance of the overall clinical outcome. Polyetheretherketone (PEEK) is a material commonly used for interbody fusion implants. Benefits of PEEK include radiolucency, less stress shielding compared to titanium implants and improved modulus which may provide better loading characteristic. The ability to better visualize the fusion at the osseous-implant junction is a benefit preferred by many surgeons. Click here to read the full white paper.

Read Article

Curiteva Announces the Beginning of the Commercial Launch of the Inspire® Posterior Interbody Solutions

Huntsville, AL (June 19, 2024) – Curiteva, Inc., a leading technology and manufacturing company, announces the commercial launch of the first of many offerings in its FDA cleared Inspire Posterior Interbody Fusion Solutions. Developed to enhance patient outcomes of transforaminal lumbar procedures, this 3D Printed Trabecular PEEK with HAFUSE Technology interbody boasts an optimized interconnected porous structure, promoting bone in-growth into and through the entire device.  

Read Article

Curiteva Surpasses 1,000 Procedures with Inspire® Cervical Trabecular PEEK™ with HAFUSE® Technology

Huntsville, AL., (June 4, 2024) – Curiteva, Inc., a privately held manufacturing and technology company, announces over 1,000 patients have been treated with the novel 3D printed Inspire Cervical Trabecular PEEK Interbody Fusion System, resulting in over 2,000 Inspire implants placed in patients. The Inspire Cervical System was introduced with limited launch in April of 2023, followed by full commercialization in July.

Read Article

Chris Schultz Joins Curiteva as Vice President of Marketing

Huntsville, AL., (May 21, 2024) – Curiteva, Inc., announced today the addition of Chris Schultz as Vice President of Marketing to the rapidly growing technology company headquartered in Huntsville, Alabama. This addition is part of a recently initiated strategy to enhance the company’s brand and propel Curiteva towards the next level of innovation and growth. This effort aligns with the company’s ongoing commitment to innovation, marked by the continuous introduction of products with its novel Inspire Technology. 

Read Article

Curiteva Announces David Schmidt as Chief Commercial Officer

Huntsville, AL (April 26, 2024) – Curiteva, a privately held manufacturing and technology company announces the appointment of David Schmidt as Chief Commercial Officer, marking a significant milestone in the company’s mission to advance innovative technology in patient care. With a distinguished career spanning over two decades, Mr. Schmidt brings unparalleled expertise in commercial strategy and a proven track record of success in the medical device marketplace.

Read Article

Renowned Neurosurgeon Dr. Kevin Foley Appointed to Curiteva’s Board of Directors

Huntsville, AL (February 12, 2024) – Curiteva, a privately held manufacturing and technology company announces the appointment of Kevin Foley, MD, to the board of directors. Dr. Foley is a distinguished neurosurgeon, chairman of the Semmes Murphey Neurologic and Spine Institute and a professor of neurosurgery, orthopedic surgery, and biomedical engineering at the University of Tennessee Health Science Center. 

Read Article

Inspire® 3D Printed Trabecular PEEK™ With HAFUSE® Lumbar Interbody System Cleared by FDA

Huntsville, AL based technology manufacturer Curiteva announced FDA 510(k) clearance of the Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System for use in anterior, transforaminal, posterior, and lateral lumbar interbody fusion procedures. This marks the company’s second FDA cleared 3D printed PEEK implant with HAFUSE, following the approval of the Inspire Trabecular PEEK Cervical Interbody Fusion System in February 2023.

Read Article

Curiteva Announces Commercialization of its Prowess Laminoplasty System

Curiteva, a privately held technology and manufacturing company based in Huntsville, AL, is proud to announce the commercial launch of its Prowess Laminoplasty System. The system is designed to provide surgeons with the tools they need to perform posterior decompression of the cervical spine with greater precision, accuracy, and efficiency.

Read Article

Curiteva Featured In Additive Manufacturing Media

Curiteva uses a novel 3D printing method called fused strand deposition (FSD), that is designed, programmed and built by the company. The company achieved FDA approval and is now in production for its first 3D printed PEEK implant, the cervical spine cage featured in this episode.

Read Article

Curiteva® Announces FDA Clearance of Pedicle & SI Navigation Instrument System

Huntsville, AL based technology company Curiteva® announces FDA 510(k) clearance to market a Navigation Instrument System to complement their Prodigy® Pedicle Screw System and SI-LUTION® Sacroiliac Joint Fusion Systems. The pioneers in 3D printed PEEK interbody fusion technology designed these instruments to integrate seamlessly with the market leading navigation system assisting surgeons in precisely locating anatomical structures for open and MIS procedures.

Read Article